Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma

Clinical and Experimental Metastasis

Volumn 32, Issue 1, 2015, Pages 55-63

  da Silva, Sabrina Daniela ^a,b   Morand, Grégoire B ^a   Alobaid, Faisal A ^a   Hier, Michael P ^a   Mlynarek, Alex M ^a   Alaoui Jamali, Moulay A ^a   Kowalski, Luiz Paulo ^b  

^a MCGILL UNIVERSITY   (Canada)

^b A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Epithelial mesenchymal transition; Metastasis; Multiple primaries; Oral cancer; Recurrence

Indexed keywords

ALPHA CATENIN; APC PROTEIN; BETA CATENIN; COLLAGEN TYPE 4; CYCLIN D1; HERMES ANTIGEN; KI 67 ANTIGEN; PLAKOGLOBIN; UVOMORULIN; CADHERIN; CATENIN; CD44 PROTEIN, HUMAN; PARAFFIN; TUMOR MARKER;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CELL INFILTRATION; DOWN REGULATION; EMBOLISM; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; MULTIPLE CANCER; OVERALL SURVIVAL; PROTEIN EXPRESSION; SECOND CANCER; SURVIVAL RATE; TISSUE MICROARRAY; BIOSYNTHESIS; HEAD AND NECK TUMOR; MIDDLE AGED; MORTALITY; MOUTH TUMOR; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TISSUE PRESERVATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; BETA CATENIN; CADHERINS; CARCINOMA, SQUAMOUS CELL; CATENINS; CYCLIN D1; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASMS, MULTIPLE PRIMARY; PARAFFIN EMBEDDING; PROGNOSIS; TISSUE PRESERVATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84928277748     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-014-9690-1     Document Type: Article

References (50)

1. Billroth T (1882) Die Allgemeine Chirurgische Pathologie und Therapie In 51 Vorlesungen: Ein Handbuch für Studierende und Aerzte. R Riemer, Berlin 980
2. Gan SJ et al (2013) Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers. Cancer 119(14):2593–2601
3. Bold B et al (2008) Usefulness of PET/CT for detecting a second primary cancer after treatment for squamous cell carcinoma of the head and neck. Clin Nucl Med 33(12):831–833
4. van Oijen MG et al (2000) The origins of multiple squamous cell carcinomas in the aerodigestive tract. Cancer 88(4):884–893
5. Stokkel MP et al (1999) 18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer. Cancer 86(11):2370–2377
6. McGarry GW et al (1992) Multiple primary malignant tumours in patients with head and neck cancer: the implications for follow-up. Clin Otolaryngol Allied Sci 17(6):558–562
7. Liao LJ et al (2013) The impact of second primary malignancies on head and neck cancer survivors: a nationwide cohort study. PLoS One 8(4):e62116
8. Slaughter DP, Southwick HW, Smejkal W (1953) Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6(5):963–968
9. Perez-Ordonez B, Beauchemin M, Jordan RC (2006) Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol 59(5):445–453
10. Califano J et al (2000) Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res 6(2):347–352
11. Califano J et al (1996) Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56(11):2488–2492
12. Braakhuis BJ et al (2002) Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 24(2):198–206
13. Tabor MP et al (2002) Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 161(3):1051–1060
14. Bedi GC et al (1996) Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res 56(11):2484–2487
15. Koukourakis MI et al (2012) Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer. Br J Cancer 106(5):846–853
16. Yang CC et al (2013) Membrane type 1 matrix metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells. BMC Cancer 13:171
17. La Fleur L, Johansson AC, Roberg K (2012) A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment. PLoS One 7(9):e44071
18. Biddle A, Mackenzie IC (2012) Cancer stem cells and EMT in carcinoma. Cancer metastasis rev 31(1–2):285–293
19. Chen C et al (2013) Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma. Cancer Lett 338(1):47–56
20. Berx G et al (2007) Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer. Clin Exp Metastasis 24(8):587–597
21. Lee JM et al (2006) The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172(7):973–981
22. Edme N et al (2002) Ras induces NBT-II epithelial cell scattering through the coordinate activities of Rac and MAPK pathways. J Cell Sci 115(12):2591–2601
23. Lo Muzio L (2001) A possible role for the WNT-1 pathway in oral carcinogenesis. Crit Rev Oral Biol Med 12(2):152–165
24. Boyer B, Valles AM, Edme N (2000) Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol 60(8):1091–1099
25. O’Sullivan B, Shah J (2003) New TNM staging criteria for head and neck tumors. Semin Surg Oncol 21(1):30–42
26. Wahi PN et al (1971) Histological typing of oral and oropharyngeal tumours. World Health Organization, Geneva, pp 17–18
27. da Silva SD et al (2014) TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target. Cancer 120(3):352–362
28. Kononen J et al (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4(7):844–847
29. Kokko LL et al (2011) Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma. Oral Oncol 47(6):510–516
30. Goldman M et al (2013) The UCSC Cancer Genomics Browser: update 2013. Nucl acids res 41(Database issue):D949–954
31. Hafner C et al (2002) Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies. Int J Cancer 101(1):1–6
32. Mani SA et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4):704–715
33. Liu LK et al (2010) Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome. Mod pathol 23(2):213–224
34. Tanaka N et al (2003) Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. Br J Cancer 89(3):557–563
35. Tanaka F et al (2013) Snail promotes Cyr61 secretion to prime collective cell migration and form invasive tumor nests in squamous cell carcinoma. Cancer Lett 329(2):243–252
36. Huber GF et al (2011) Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx. BMC Cancer 11(217):1–8
37. Smith A, Teknos TN, Pan Q (2013) Epithelial to mesenchymal transition in head and neck squamous cell carcinoma. Oral Oncol 49(4):287–292
38. Ishida K et al (2007) Nuclear localization of beta-catenin involved in precancerous change in oral leukoplakia. Mol Cancer 6:62
39. Alami J, Williams BR, Yeger H (2003) Differential expression of E-cadherin and beta catenin in primary and metastatic Wilms’s tumours. Mol Pathol 56(4):218–225
40. Etienne-Manneville S (2008) Polarity proteins in migration and invasion. Oncogene 27(55):6970–6980
41. Hanken H et al (2014) CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas. Clin Oral Invest 18(1):269–276
42. Klimowicz AC et al (2013) The prognostic impact of a combined carbonic anhydrase IX and Ki67 signature in oral squamous cell carcinoma. Br J Cancer 109(7):1859–1866
43. Gonzalez-Moles MA et al (2010) Analysis of Ki-67 expression in oral squamous cell carcinoma: why Ki-67 is not a prognostic indicator. Oral Oncol 46(7):525–530
44. Perisanidis C et al (2012) Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma. J Oral Pathol Med 41(1):40–46
45. Pich A, Chiusa L, Navone R (2004) Prognostic relevance of cell proliferation in head and neck tumors. Ann Oncol 15(9):1319–1329
46. Li L, Bhatia R (2011) Stem cell quiescence. Clin Cancer Res 17(15):4936–4941
47. Hildebrand LC et al (2014) Spatial distribution of cancer stem cells in head and neck squamous cell carcinomas. J Oral Pathol Med 34(1):11–18
48. Mack B, Gires O (2008) CD44s and CD44v6 expression in head and neck epithelia. PLoS One 3(10):e3360
49. Georgolios A et al (2006) The role of CD44 adhesion molecule in oral cavity cancer. Exp Oncol 28(2):94–98
50. Ritchie KE, Nor JE (2013) Perivascular stem cell niche in head and neck cancer. Cancer Lett 338(1):41–46